Dr. Lal PathLabs (LALPATHLAB.NS) Stock Price
Dr. Lal PathLabs Price
Over the last 15 years Dr. Lal PathLabs grew revenue by 17.8% annually, reaching 27.63 B INR. Earnings per share have grown at 20.9% per year over the last 15 years. For Dr. Lal PathLabs, the net margin of 18.3% is up versus 16.5% a few years ago. At today's price the dividend yield works out to roughly 0.71%. The payout ratio is around 52% of earnings. The dividend has grown at 26.6% per year over the past 10 years. The consensus 12-month price target for Dr. Lal PathLabs is 1,774.80 INR, about 3.7% below where the stock trades today. Of 29 analysts, 21 rate the stock a buy — an overall Buy consensus.
Dr. Lal PathLabs stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Dr. Lal PathLabs business model & stock analysis
Frequently asked questions about Dr. Lal PathLabs
Dr. Lal PathLabs Ltd operates as a leading diagnostic company in India. The company's business model primarily revolves around offering a comprehensive range of clinical laboratory diagnostic services. They provide a wide array of tests and screenings, including pathology, radiology, genetic testing, and more. Dr. Lal PathLabs is known for its state-of-the-art facilities, advanced technologies, and a network of well-trained professionals. Through their extensive presence across India, they cater to various healthcare institutions, doctors, and individual customers, ensuring accurate and timely diagnostic solutions. With a focus on quality assurance and customer satisfaction, Dr. Lal PathLabs Ltd continues to play a significant role in the healthcare industry.
Dr. Lal PathLabs Ltd is primarily active in the healthcare and diagnostics industry.
The main competitors of Dr. Lal PathLabs Ltd in the market include companies such as Thyrocare Technologies Ltd, Metropolis Healthcare Ltd, and SRL Diagnostic.
Dr. Lal PathLabs Ltd is a leading diagnostic and healthcare service provider in India. Established in 1949 by Dr. S.K. Lal, the company has grown to become one of the most trusted names in the industry. With a strong focus on innovation and quality, Dr. Lal PathLabs offers a wide range of diagnostic tests and services, catering to both individual and institutional customers. Over the years, the company has expanded its network across the country, with a vast presence in more than 200 cities. With its commitment to accuracy, reliability, and customer satisfaction, Dr. Lal PathLabs has emerged as a pioneer in the field of diagnostic services in India.
Dr. Lal PathLabs Ltd, a leading diagnostic and healthcare service provider, has achieved several significant milestones. With a commitment to excellence, the company has expanded its presence across India, serving millions of patients. Dr. Lal PathLabs has implemented cutting-edge technology and state-of-the-art infrastructure, enabling accurate and timely diagnostic solutions. Their continuous focus on delivering quality services and offering a comprehensive test menu has gained them recognition and trust among healthcare professionals and patients. Dr. Lal PathLabs has also received numerous awards and accreditations, highlighting their unparalleled commitment to customer satisfaction and healthcare innovation.
Dr. Lal PathLabs Ltd is primarily present across various regions in India. With a strong network, the company serves numerous cities, including major urban centers such as Delhi, Mumbai, Chennai, and Kolkata. Dr. Lal PathLabs Ltd has established a significant presence in multiple states across India, ensuring accessibility to its diagnostic services.
Dr. Lal PathLabs Ltd is guided by a strong set of values and corporate philosophy. The company believes in providing accurate and reliable diagnostic services, with a commitment to ethical practices and patient-centric care. Dr. Lal PathLabs Ltd strives to maintain the highest standards of quality, both in terms of testing procedures and customer service. With a focus on innovation and advanced technology, the company aims to continually improve its services and contribute to the healthcare industry. Dr. Lal PathLabs Ltd's dedication to excellence and integrity has positioned it as a trusted name in the field of diagnostics.
Analysts currently set an average price target of 1,713.67 INR for the Dr. Lal PathLabs stock (median: 1,774.80 INR), implying -7.1 % versus the latest price. The consensus is based on 29 analyst ratings.
29 analysts currently rate the Dr. Lal PathLabs stock: 22 recommend buying, 2 holding and 5 selling.
Converted at the current exchange rate, the Dr. Lal PathLabs share trades at 17.38 EUR (1,843.70 INR).
The Dr. Lal PathLabs share (LALPATHLAB.NS) is listed on 2 stock exchanges, including: NSE (Indien) (LALPATHLAB.NS).
Dr. Lal PathLabs Ltd is a leading company in the Indian diagnostic market, offering a comprehensive range of laboratory tests and services. With over 190 laboratories and 2,600 patient collection centers across India, the company aims to provide patients with fast, accurate, and reliable diagnoses. The business model of Dr. Lal PathLabs Ltd is based on a wide portfolio of laboratory tests and services, ranging from the diagnosis of infectious diseases to cancer diagnostics. The company is divided into three main divisions: laboratory diagnostics, pathology, and radiology. Laboratory diagnostics include a variety of tests such as blood tests, urine tests, stool tests, hepatitis tests, and many more. These tests help diagnose a variety of diseases and enable early detection of symptoms that may indicate serious illnesses. The pathology department of Dr. Lal PathLabs Ltd offers tissue and fluid analysis, allowing the company to make accurate diagnoses and provide patients with the best possible treatment. Additionally, the company also offers cytology and histopathology tests that can aid in the diagnosis of some of the most common and serious types of cancer. The radiology department of Dr. Lal PathLabs Ltd offers a wide range of imaging services, including conventional X-rays, ultrasound scans, mammograms, and CT scans. These tests help diagnose conditions such as breast cancer, lung cancer, and other serious illnesses that require early treatment. Dr. Lal PathLabs Ltd also provides specialized tests such as genetic tests and immunological tests. These tests can aid in the diagnosis of genetic diseases and autoimmune diseases, as well as predict disease risks in patients. The company has earned a reputation as a reliable and high-quality diagnostic provider, based on advanced technology, strict quality standards, and a dedicated workforce. An important part of Dr. Lal PathLabs Ltd's business model is its patient service model, which aims to provide patients with an efficient and pleasant experience. This includes fast and reliable testing and reporting services, as well as comprehensive support from the customer service team. Overall, Dr. Lal PathLabs Ltd's business model is based on a strong market position, a wide range of diagnostic tests and services, and a focus on quality and patient service. The company is expected to continue to grow and solidify its position as a leading provider of diagnostic and laboratory services in India.
The revenue of Dr. Lal PathLabs is 27.63 B INR. This figure is based on current financial data and reflects the company's business performance.
The profit of Dr. Lal PathLabs is 5.05 B INR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Dr. Lal PathLabs is currently 61.11. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Dr. Lal PathLabs stock.
The price-to-sales ratio (P/S) of Dr. Lal PathLabs is currently 11.17. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Dr. Lal PathLabs stock.
The Eulerpool Quality Score for Dr. Lal PathLabs is 7/10.
The ISIN of Dr. Lal PathLabs is INE600L01024. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Dr. Lal PathLabs is LALPATHLAB.NS. The ticker symbol is used to trade Dr. Lal PathLabs shares on the stock exchange.
Dr. Lal PathLabs stock
Dr. Lal PathLabs Peer Group
Dr. Lal PathLabs Ticker
Dr. Lal PathLabs FIGI
All fundamentals and in-depth analysis of Dr. Lal PathLabs
Our stock analysis for Dr. Lal PathLabs stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Dr. Lal PathLabs. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.